Brief: Seres Therapeutics QTRLY Loss Per Share $2.27
06/08/2025 14:14
Aug 6 (Reuters) - Seres Therapeutics Inc MCRB.O: SERES THERAPEUTICS INC: QTRLY LOSS PER SHARE $2.27 SERES THERAPEUTICS INC: EXPECTS TO FUND OPERATIONS INTO Q1 2026 SERES THERAPEUTICS: CONTINUES TO EVALUATE COST REDUCTION ACTIONS AIMED AT EXTENDING CASH RUNWAY Source text: ID:nGNX9qZgzt Further company coverage: MCRB.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Seres Therapeutics
See all newsChinese automakers make tech-led pitch for Europe's premium car market
Brief: Seres Therapeutics - May Offer Up To $300 Million Of Securities
Seres Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Seres Therapeutics Q2 net income turns positive on VOWST sale gain
Brief: Seres Therapeutics Q2 EPS USD 0.47